Cargando…
In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery
This is an in vitro study conducted to observe the safety and antiscarring effects of combined application of bevacizumab (BVZ) and 5-fluorouracil (5-Fu) or BVZ and mitomycin C (MMC) during glaucoma filtration surgery (GFS). The cytotoxicity of drug combinations in human Tenon's fibroblasts (HT...
Autores principales: | Zhang, Yuanyuan, Zhu, Shaopin, Xu, Xun, Zuo, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925728/ https://www.ncbi.nlm.nih.gov/pubmed/31885893 http://dx.doi.org/10.1155/2019/7419571 |
Ejemplares similares
-
Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery
por: Zuo, Lei, et al.
Publicado: (2018) -
Anti-scarring effects of conbercept on human Tenon’s fibroblasts: comparisons with bevacizumab
por: Zuo, Lei, et al.
Publicado: (2023) -
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed, Ahmed M, et al.
Publicado: (2014) -
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
por: Marey, Hatem M, et al.
Publicado: (2011) -
Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: a case series
por: de Moraes, Carlos Gustavo Vasconcelos, et al.
Publicado: (2009)